A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aad7666
PubMed Identifier: 26936507
Publication URI: http://europepmc.org/abstract/MED/26936507
Type: Journal Article/Review
Volume: 8
Parent Publication: Science translational medicine
Issue: 328
ISSN: 1946-6234